Inventor
KEMP Mark
US9 patents
⚠️ This page may combine multiple inventors who share the name “KEMP Mark”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MISSION THERAPEUTICS LTD
7 patentsUS10689345B2Jun 23, 2020
1-cyano-pyrrolidine compounds as USP30 inhibitors
MISSION THERAPEUTICS LTD4 citations81
US10343992B2Jul 9, 2019
1-cyano-pyrrolidine compounds as USP30 inhibitors
MISSION THERAPEUTICS LTD7 citations81
US11390584B2Jul 19, 2022
1-cyano-pyrrolidine compounds as USP30 inhibitors
MISSION THERAPEUTICS LTD1 citations70
US11319287B2May 3, 2022
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
MISSION THERAPEUTICS LTD0 citations60
US11066365B2Jul 20, 2021
1-cyano-pyrrolidine compounds as USP30 inhibitors
MISSION THERAPEUTICS LTD0 citations60
US11053198B2Jul 6, 2021
1-cyano-pyrrolidine compounds as USP30 inhibitors
MISSION THERAPEUTICS LTD0 citations60
US10669234B2Jun 2, 2020
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
MISSION THERAPEUTICS LTD1 citations60